drugset / Trial / NCT04383691
A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
Phase 3
Terminated
124 enrolled
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Sumitomo Pharma America, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study evaluates the efficacy and safety of lurasidone compared with placebo in treating Bipolar I Depression.
Timeline
- Start
- 2020-12-11
- Primary completion
- 2022-12-23
- Completion
- 2022-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 20 mg | Oral |
| Subject | Lurasidone | Small molecule | 120 mg | Oral |